Alan L Ho Selected Research

Salivary Gland Neoplasms (Salivary Gland Cancer)

5/2022	Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
12/2021	Androgen Receptor Pathway in Salivary Gland Cancer.
1/2020	Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
1/2018	Challenges and Opportunities for Developing New Therapeutics for Salivary Gland Cancers.
10/2017	Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.
2/2017	Androgen Receptor Signaling in Salivary Gland Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan L Ho Research Topics

Disease

39	Neoplasms (Cancer) 10/2022 - 04/2009
14	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 01/2011
8	Carcinoma (Carcinomatosis) 06/2022 - 09/2016
6	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2022 - 02/2017
5	Squamous Cell Carcinoma of Head and Neck 10/2021 - 11/2013
4	Disease Progression 06/2022 - 06/2014
3	Anemia 01/2022 - 08/2017
3	Adenoid Cystic Carcinoma (Cylindroma) 01/2020 - 08/2011
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 05/2013
2	Oropharyngeal Neoplasms 11/2021 - 01/2021
2	Papillary Thyroid Cancer 01/2021 - 01/2021
2	Stomatitis 01/2020 - 11/2017
2	Lung Neoplasms (Lung Cancer) 01/2020 - 08/2011
2	Anaplastic Thyroid Carcinoma 01/2018 - 12/2011
2	Fatigue 11/2017 - 05/2013
2	Hyperglycemia 11/2017 - 05/2013
2	Uveal melanoma 05/2013 - 01/2012
2	Melanoma (Melanoma, Malignant) 04/2013 - 01/2012
2	Sarcoma (Soft Tissue Sarcoma) 04/2013 - 09/2012
2	Polyploidy 02/2012 - 04/2009
1	Dermatitis 10/2022
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Infections 08/2020
1	Carcinogenesis 01/2018
1	Merkel Cell Carcinoma 01/2018
1	Retinal Detachment (Retinal Detachments) 12/2017
1	Central Serous Chorioretinopathy 12/2017
1	Multiple Myeloma 08/2017
1	Hyperhidrosis 08/2017
1	Hypertension (High Blood Pressure) 08/2017
1	Lymphoma (Lymphomas) 08/2017
1	Nausea 08/2017

Drug/Important Bio-Agent (IBA)

7	IodineIBA 10/2022 - 02/2013
5	Pharmaceutical PreparationsIBA 10/2022 - 01/2012
5	Phosphotransferases (Kinase)IBA 05/2022 - 01/2011
4	PlatinumIBA 01/2020 - 05/2013
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2017 - 01/2012
3	AZD 6244IBA 10/2022 - 01/2012
3	VemurafenibIBA 01/2022 - 01/2019
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2013
3	tipifarnib (R115777)IBA 10/2021 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2013
3	taxaneIBA 12/2017 - 05/2013
3	Everolimus FDA Link 11/2013 - 09/2012
3	TOR Serine-Threonine KinasesIBA 11/2013 - 01/2012
2	larotrectinibIBA 06/2022 - 05/2022
2	Thyroglobulin FDA Link 06/2022 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 01/2020
2	Eukaryotic Initiation Factor-4EIBA 01/2022 - 11/2013
2	Biological ProductsIBA 01/2022 - 01/2011
2	Androgen Receptors (Androgen Receptor)IBA 12/2021 - 02/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2017
2	RNA (Ribonucleic Acid)IBA 01/2020 - 09/2016
2	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2014
2	5'-N-methylcarboxamideadenosineIBA 01/2020 - 10/2017
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 04/2015
2	NVP-BKM120IBA 12/2017 - 04/2015
2	Carboplatin (JM8)FDA LinkGeneric 12/2017 - 04/2015
2	temsirolimus FDA Link 11/2017 - 04/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2013 - 09/2012
1	TropomyosinIBA 05/2022
1	Thyrotropin Alfa FDA LinkGeneric 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	Iodine-124IBA 01/2022
1	Ribavirin (Virazole)FDA LinkGeneric 01/2022
1	Activins (Activin)IBA 01/2021
1	LigandsIBA 01/2021
1	ChromatinIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020
1	Radiation-Sensitizing AgentsIBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	AlpelisibIBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	trastuzumab deruxtecanIBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	afliberceptIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	AntigensIBA 01/2019
1	lenvatinibIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Nonsense Codon (Nonsense Mutation)IBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 11/2017
1	Bendamustine Hydrochloride FDA Link 08/2017
1	Rituximab (Mabthera)FDA Link 08/2017
1	Alkylating AgentsIBA 08/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2017
1	veliparibIBA 08/2017

Therapy/Procedure

21	Therapeutics 06/2022 - 08/2011
9	Drug Therapy (Chemotherapy) 12/2017 - 08/2011
7	Radiotherapy 01/2021 - 12/2011
3	Immunotherapy 01/2020 - 01/2019
2	Drug Tapering 01/2022 - 01/2020